Evaluating the Results of Physician & Parent Decisions to Treat Selective

Status Completed

Clinical Trial Summary

The Department of Counseling, Educational Psychology, and Special Education and the Department of Psychiatry at Michigan State University have coordinated efforts to provide a diagnostic and treatment investigation for children, ages seven to eighteen, with Selective Mutism. The purpose of this study is to examine the utility of fluoxetine for the treatment of this debilitating disorder. Fluoxetine is expected to improve social anxiety and selective mutism symptomology.

Clinical Trial Description

Children with selective mutism (SM) are at risk for current and continuing academic and socio-emotional difficulties. Unfortunately, this issue is complicated by the fact these children often respond poorly to psychosocial intervention. This leaves parents with the overwhelming decision to attempt a trial of medication regardless of the little available data on the evidence base of this approach. Despite the paucity of research, psychiatrists are prescribing fluoxetine for children with SM "off label", as the Food and Drug Administration (FDA) has yet to approve fluoxetine for this indication. This study blends the psychopharmacological expertise of psychiatrists with the mental health, systems, and psychological evaluation expertise of school psychologists to identify an appropriate psychopharmacological solution for children and adolescents with this debilitating disorder. To that end, this study will examine the utility of fluoxetine for the treatment of five children and adolescents, ages seven to eighteen, diagnosed with SM through the use of a non-concurrent multiple-baseline single-case design with a single-blind placebo-controlled procedure. Treatment effectiveness will be evaluated by visual analysis of the data, the Wampold and Worsham multiple-baseline design randomization test, and the Kendall's Tau + Mann-Whitney U effect size. Multiple methods of assessment including standardized measures, such as the Selective Mutism Questionnaire (SMQ), and behavior ratings, such as Direct Behavior Ratings (DBRs), will be used to gather baseline and treatment data. Multiple informants (i.e., parents, teachers, and psychiatrists) will provide information on treatment effect across settings (i.e., school and community). Information regarding adverse effects associated with fluoxetine treatment including a measure of behavioral disinhibition, parental acceptance of the fluoxetine intervention, and compliance with taking the medication will also be gathered. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05378711
Study type	Interventional
Source	Michigan State University
Contact
Status	Completed
Phase	Phase 2
Start date	January 1, 2014
Completion date	May 30, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05168020` - Evaluation of a Self-Monitoring Intervention to Reduce Safety Behavior in Social Anxiety	N/A
Not yet recruiting	`NCT06020170` - Delving Into Participation Patterns in Social Anxiety Studies
Completed	`NCT03297619` - Self-help Books for Social Anxiety	N/A
Completed	`NCT04509531` - Building Resilience in Cyberbullying Victims	N/A
Recruiting	`NCT04859790` - Acceptability/Feasibility Testing of SCAR	N/A
Completed	`NCT05576259` - oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder	N/A
Completed	`NCT05858294` - The Safety, Acceptability and Efficacy of Alena	N/A
Completed	`NCT04450303` - Social Anxiety Telehealth Therapy Study	N/A
Completed	`NCT03601377` - Attention Bias Modification Treatment in Social Anxiety	N/A
Completed	`NCT03671577` - Building Closer Friendships in Social Anxiety Disorder	N/A
Not yet recruiting	`NCT06081348` - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders	Phase 2
Recruiting	`NCT05554718` - Evaluation of a Smartphone Application for Self-help for Social Anxiety	N/A
Completed	`NCT02534948` - Feasibility Study of Mindfulness and Acceptance Based Group Therapy for Social Anxiety	N/A
Completed	`NCT03249116` - Assessing Mechanisms of Anxiety Reduction in Animal-assisted Interventions	N/A
Completed	`NCT05159037` - Using the Musical Track From GC-MRT as a Treatment Booster in Stressful Situations	N/A
Completed	`NCT03711513` - Facing Fears by Focussing on Behaviour, Body, or Mind?	N/A
Completed	`NCT04845100` - Animal Assisted Activities on the Stress and Social Anxiety	N/A
Active, not recruiting	`NCT04276363` - Families, Children and Teachers Thriving Together	N/A
Completed	`NCT05372744` - Affect-regulatory Characteristics of Deceptive Placebos	N/A
Recruiting	`NCT05798078` - The Relationship Between Social Anxiety and Anxious Thinking Styles	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms